Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Biomarker Research

Fig. 2

From: Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer

Fig. 2

Calibration curves. a The standard curve from an ELISA for Ln-γ2 using a conventional Ln-γ2 antibody, the D4B5 mAb, and the DIII pAbs. The detection range was 200–20,000 pg/mL. b The standard curve for the chemiluminescence immunoassay (CLIA) using the 2H2 mAb and the DIII pAbs. The detection range was 10–20,000 pg/mL. The CLIA had 20-fold greater sensitivity compared with the sandwich ELISA. c Standard curve for Ln-332 using the CLIA with an anti-Ln-α3 mAb and the anti-DIII pAbs. The detection range was 100–10,000 pg/mL

Back to article page